ORIGINAL
Impacto de la tecnología híbrida PET/RM con 18F-colina en la estrategia terapéutica de los pacientes con cáncer de próstata tratados con prostatectomía que presentan elevación del antígeno prostático específico inferior a 1 ng/ml
Value of 18F-Choline PET/MRI hybrid technique on the therapeutic approach for patients with prostate cancer treated with prostatectomy and rising prostate specific antigen levels below 1 ng/ml
J.R. García
, A. Compte, M. Buxeda, S. Mourelo, M. Soler, A. Blanch, E. Valls, E. Riera.
Autor para correspondencia
CETIR, ASCIRES, Barcelona, España
LeÃdo
945
Vecesse ha leÃdo el artÃculo
382
Total PDF
563
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 1 | 3 | 4 |
| 2025 4 | 1 | 1 | 2 |
| 2023 9 | 0 | 1 | 1 |
| 2023 3 | 2 | 0 | 2 |
| 2022 3 | 2 | 2 | 4 |
| 2021 11 | 1 | 2 | 3 |
| 2021 5 | 1 | 2 | 3 |
| 2021 4 | 11 | 18 | 29 |
| 2021 3 | 4 | 2 | 6 |
| 2021 2 | 11 | 8 | 19 |
| 2020 1 | 281 | 158 | 439 |
| 2020 12 | 98 | 64 | 162 |
| 2020 11 | 62 | 31 | 93 |
| 2020 10 | 56 | 48 | 104 |
| 2020 9 | 1 | 2 | 3 |
| 2020 8 | 14 | 13 | 27 |
| 2020 7 | 17 | 17 | 34 |
| 2020 5 | 0 | 2 | 2 |
| 2020 4 | 0 | 6 | 6 |
| 2020 3 | 0 | 2 | 2 |
Mostrar todo
